Phase 3 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older at the time of signing the consent form
- People who have been diagnosed with nerve pain caused by a herniated disc in the lower back, and who have already been scheduled for surgery in a neurosurgery department
- People who are covered by a social security health insurance scheme
- People who are able to understand the goals and risks of the research and can give written, signed, and dated consent
- People who have been informed of the results of their pre-study medical check-up
- Women who could become pregnant, provided that a blood pregnancy test recorded at the first visit comes back negative and that effective contraception is used throughout the study
Who may not be able to join:
- People who have previously had surgery on their lower back, or who have multiple herniated discs, or a herniated disc in a location other than the lower back
- People who have HIV, active cancer, hepatitis B (HBV), or hepatitis C (HCV), as confirmed by interview
- People who take corticosteroid medication (such as steroids) on a long-term, ongoing basis throughout the body
- People whose overall health risk, as assessed by an anaesthesiologist, is rated above a certain level (known as an ASA score greater than 3 — confirm with trial site)
- People who are unable to give informed consent, for example due to an emergency situation, a life-threatening condition, or difficulties understanding information
- People who are currently in an exclusion period as a result of a previous or ongoing clinical study
- People who are under the protection of a justice safeguard order
- People who are under a legal curatorship arrangement
- People who are pregnant
- People who are breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 3 88 12 85 02
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess the effectiveness of periricular intraoperative application of Platelet- and Fibrin-enriched plasma (PRF) on the intensity of residual neuropathic pain postoperatively with primary herniated disc surgery.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.